The European Chemicals Agency’s (ECHA) Committee for Socio-Economic Analysis (SEAC) has adopted final opinions backing EU-wide restrictions on per- and polyfluoroalkyl substances (PFAS) and certain chromium(VI) compounds — a development manufacturers will need to track closely.
What did ECHA decide on PFAS?
Announced yesterday, the SEAC’s opinion supports a PFAS ban with use-specific derogations, concluding that EU-wide action is needed to address risks and maintain a level playing field.
It recommends derogations only where justified by evidence, transition periods to allow time to develop alternatives and time-limited derogations for some sectors pending further evaluation.
The SEAC also said that it supports additional measures to minimise PFAS emissions from derogated uses, as recommended by the Committee for Risk Assessment (RAC).
However, it found insufficient information to assess their costs and benefits.
PFAS and their degradation products are highly persistent and can contaminate groundwater and soil and both committees say existing regulatory measures are insufficient.
What about chromium(VI)?
The SEAC concluded that two restriction options are proportionate, provided appropriate transition periods apply.
It favoured the more ambitious option two as the best balance between reducing exposure to these carcinogenic substances and socio-economic impact and added it considers more stringent options unlikely to be proportionate.
The committee said that it recommends a transition period of at least 36 months and, with RAC, calls for guidelines to support implementation and enforcement.
Apart from barium chromate, the substances covered are Substances of Very High Concern (SVHCs) on the REACH Authorisation List.
SEAC Chair Maria Ottati said the committee had “carefully balanc[ed] the societal costs and benefits” to ensure the restrictions are “proportionate and workable in practice."
What happens next?
The opinions will be finalised in the coming weeks and sent, with RAC’s final opinions and background documents, to the European Commission and published on ECHA’s website.
The Commission will then propose restrictions for discussion and a vote in the REACH Committee of EU Member States.
New study notification duty
Separately, ECHA announced on Tuesday that businesses and laboratories have a year to prepare for a new obligation to notify ECHA of certain chemical studies, applying from 2 November 2027.
Under Regulation (EU) 2025/2455, both the commissioning business and the laboratory or testing facility must notify ECHA. The commissioning party must also tell the lab that the obligation applies.
It applies only to studies commissioned on or after that date, plus, not every study will qualify.
Studies notified through the European Food Safety Authority’s (EFSA) system are excluded.
Notifications will be held in a confidential database, with related information made public via the Common Data Platform on Chemicals once the corresponding dossier is submitted.
Why it matters for pharma manufacturers
Manufacturers should review supply chains for PFAS-containing materials and chromium(VI)-based processes and engage with suppliers early.
Companies commissioning regulatory studies should also clarify responsibilities with their laboratory partners well before November 2027.